The role of Nuclear Medicine in the management of thymomas


COD: 371-374 Categorie: ,

Giorgio Treglia, Maria Grazia Spitilli, Maria Lucia Calcagni, Alessandro Giordano

Ann. Ital. Chir., 2007; 78: 371-374

La mia nuova descrizione qui!

Price of a print issue €25.00

AIM OF THE STUDY: To evaluate the role of nuclear medicine techniques in the management of patients with thymoma.
MATERIALS AND METHODS: The Authors performed a review of the literature about the usefulness of traditional nuclear
medicine and positron emission tomography in patients with thymic tumours.
RESULTS AND DISCUSSION: Nuclear medicine imaging can provide additional information in cases of thymoma such as
in differential diagnosis between thymic tumours, staging and restaging. Thallium-201 (201Tl), 99mTc-sestamibi and 99mTctetrofosmin
are useful tumour-imaging agent. Another radiopharmaceutical useful in the management of thymomas is
111In-pentetreotide, a somatostatin analogue, used to define the receptor status and the extent of disease in malignant
thymomas. Positron emission tomography (PET) is a powerful diagnostic tool for diagnosis, staging and restaging of neoplasms
in general. The most used PET radiopharmaceutical is the fluorodeoxyglucose (18F-FDG), a glucose analogue. The
uptake of FDG reflects the metabolic activity of organs and neoplasms and correlates with the tumour growth rate. There
is a paucity of literature on the use of PET scanning in the diagnosis of thymoma. Further perspective studies with a
larger number of cases, considering the development of hybrid imaging PET-CT and new PET radiopharmaceuticals,
may increase the role of nuclear medicine in the diagnostic and therapeutic management of thymic neoplasms.


Utilizzando il sito, accetti l'utilizzo dei cookie da parte nostra. maggiori informazioni

Questo sito utilizza i cookie per fornire la migliore esperienza di navigazione possibile. Continuando a utilizzare questo sito senza modificare le impostazioni dei cookie o cliccando su "Accetta" permetti il loro utilizzo.